david haas Archives
Bloch, Haas appointed interim leaders of the Division of Infectious Diseases
Jan. 3, 2022—Karen Bloch, MD, MPH, and David Haas, MD, have been appointed interim leaders of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center.
Clinical Trials Unit lands major grant renewal
Feb. 11, 2021—Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have received renewal of a major federal grant to continue their collaboration to test and develop new treatments and vaccines against HIV/AIDS — and now COVID-19.
VUMC launches clinical trial of outpatient treatments for COVID-19
Sep. 2, 2020—Vanderbilt University Medical Center is now enrolling volunteers for a clinical trial of promising treatments for COVID-19 in the outpatient setting.
Center for AIDS Research lands NIH grant renewal
May. 7, 2020—The National Institutes of Health (NIH) has renewed its support of the Tennessee Center for AIDS Research (CFAR), a four-way partnership between Vanderbilt University Medical Center, Meharry Medical College, the Tennessee Department of Health and Nashville CARES.
VUMC, Meharry and State Health Department receive NIH grant to establish AIDS research center
Jun. 25, 2015—Vanderbilt University has received a five-year grant from the National Institutes of Health (NIH) to establish the Tennessee Center for AIDS Research with Meharry Medical College and the Tennessee Department of Health.
AIDS Clinical Trials Unit lands renewal of NIH funding
Jan. 30, 2014—Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).
Genetic testing just one weapon in HIV/AIDS fight
Jan. 24, 2013—Genetic testing has revolutionized the treatment of patients with HIV/AIDS. But it is not a panacea.
